CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

A Lennar Company

Margarita Rivera-Santiago, CISSP, CISM, CRISC, CISA – Vice President of Information Security Risk & Compliance - LMC

How Technology Is Revolutionizing Compliance Responsibilities

Margarita Rivera-Santiago

Margarita Rivera-Santiago

Never has there been a time where regulatory compliance responsibilities are as overwhelming as they are today. Regulatory pressures for corporate compliance will only continue to increase as digital innovation disrupts the traditional and replaces it with sleek technology that processes data more efficiently than ever before. With the volume of information ever increasing, it has become harder and harder to balance between thoroughness and agility. If that is not complicated enough, the mere volume of data and variety of approaches makes it difficult to truly determining compliance. These competing demands require alternatives that do not leave organizations exposed to compliance failures.


That is where compliance technology steps in. Through the use of compliance technology, the mere nature of compliance responsibilities has shifted and will continue to shift from one of a tactical nature to more strategic. Compliance technology at its onset was nothing more than a large data storage location for documentation repository and has now evolved into a more analytically driven tool. Compliance technology is now allowing for the parsing and analysis of information even before a set of eyes review it. Artificial intelligence, machine learning, and automation is reducing the compliance burden and allowing for compliance professionals to strategically evaluate and manage compliance initiatives.


As a publicly traded, Fortune 500 company, technology has become a necessary tool for our management of compliance risks. Whether we are reviewing regulatory compliance like Sarbanes Oxley (SOX), internal corporate compliance to policies, privacy compliance or 3rd party vendor compliance, it would not be possible without the tools available to us today. It would cost a countless amount of resources and still not be as thorough. 


For example, when evaluating a new 3rd party product for use within our organization there is quite a bit of analysis that must take place to ensure that the product is secure and that the data that it will house will be protected. This analysis can take weeks if done manually. However, through the use of our 3rd party vendor risk management platform, we are able to automate the process and evaluate the product in days in a way that is more objective than previous approaches. That is because compliance technology now has built in algorithms like MITRE that help determine the external security posture of the product. Additionally, the platform allows for ongoing monitoring of our critical 3rd party providers which monitor the external security posture for the vendor and alerts us in real time when there has been a change. This reduces the amount of time and effort our staff has to spend on ensuring compliance by our 3rd party vendors. In the case of regulatory compliance requirements such as for SOX or when managing our privacy compliance to the General Data Protection Regulation and California Consumer Privacy Act, technology has enabled interactive work flows that neatly collect and organize compliance documentation and makes it readily available for audit purposes.


It is undoubtable that as technology and its associated functionalities continue to evolve, the use of compliance technology to perform the day to day tactical functions and provide a platform for strategic analysis will continue to be adopted by organization. The efficiencies gained through the effective management of compliance risks make it essential for corporations to properly perform compliance functions. Furthermore. as a result, compliance roles will continue to transition from tactical to more strategic in nature making it a win-win for all.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://life-science-testing.lifesciencesreview.com/leadership-perspective/how-technology-is-revolutionizing-compliance-responsibilities-nwid-296.html